Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43146 (
tumour suppressor
)
5,935
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recently, some reports show that Ligand of Numb Protein-X 1 (LNX1) could be a suppressor gene in gliomas, while our current research has firstly shown that
PDZ domain containing ring finger 4
(
PDZRN4
), another member of LNX family, could also be a potential suppressor in hepatocellular carcinoma (HCC).
PDZRN4
, also named
LNX4
(Ligand of Numb Protein-X 4), is a member of the LNX family. We recently found that
PDZRN4
, but not LNX1, was down-regulated in HCC samples, and the role of
PDZRN4
in the progression of HCC had not been studied before. To address this question, firstly, we evaluated the expression of
PDZRN4
in HCC samples and adjacent non-cancerous tissues. Semi-quantitative polymerase chain reaction showed that
PDZRN4
was down-regulated in 24/36 (66.7%) HCC samples separately. In addition, our research shows that
PDZRN4
is silenced in all of the 12 HCC cell lines tested. Subsequently, cell-based functional assay exhibited that ectopic expression of
PDZRN4
inhibits the proliferation, plate colony formation and anchorage-independent colony formation of HCC cells. Collectively, our results showed that
PDZRN4
might be a potential
tumour suppressor
gene and had anti-proliferative effect on HCC cell proliferation, which would be of great significance to the researches on HCC.
...
PMID:PDZRN4 acts as a suppressor of cell proliferation in human liver cancer cell lines. 2648 4